These success, along with a former report displaying that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,two help the idea of targeting ACKR3 as a unique approach to modulate the opioid system, which could open up new therapeutic avenues for opioid-connected disorders. (3) Other than in the https://joseone925jgb4.blogrenanda.com/profile